Stuart Titus
Director/Board Member chez GREEN GLOBE INTERNATIONAL, INC.
Fortune : 36 107 $ au 31/03/2024
Profil
Stuart W.
Titus is the founder of General Hemp LLC, which was founded in 2012, where he holds the title of President.
Currently, he is a Director at Green Globe International, Inc. since 2021.
Dr. Titus's former jobs include being the Chairman, President & Chief Executive Officer at Medical Marijuana, Inc. from 2019 to 2021, Chairman at Hempacco Co., Inc. from 2021 to 2023, and Vice President at First Boston Corp.
from 1983 to 1989.
He was also a Director at Neuropathix, Inc. Dr. Titus's education history includes an undergraduate degree from Rollins College (Florida).
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
HEMPACCO CO., INC.
0,69% | 19/10/2023 | 21 621 ( 0,69% ) | 36 107 $ | 31/03/2024 |
Postes actifs de Stuart Titus
Sociétés | Poste | Début |
---|---|---|
GREEN GLOBE INTERNATIONAL, INC. | Director/Board Member | 22/03/2021 |
General Hemp LLC | Founder | 01/10/2012 |
Anciens postes connus de Stuart Titus
Sociétés | Poste | Fin |
---|---|---|
HEMPACCO CO., INC. | Chairman | 26/10/2023 |
MEDICAL MARIJUANA, INC. | Chief Executive Officer | 17/06/2021 |
First Boston Corp. | Corporate Officer/Principal | 01/11/1989 |
NEUROPATHIX, INC. | Director/Board Member | - |
Credit Suisse First Boston Corp. | Corporate Officer/Principal | - |
Formation de Stuart Titus
Rollins College (Florida) | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
GREEN GLOBE INTERNATIONAL, INC. | Commercial Services |
MEDICAL MARIJUANA, INC. | Process Industries |
Entreprise privées | 5 |
---|---|
First Boston Corp. | Finance |
General Hemp LLC | |
Credit Suisse First Boston Corp. | Finance |
Neuropathix, Inc.
Neuropathix, Inc. Pharmaceuticals: MajorHealth Technology Neuropathix, Inc. is a biopharmaceutical company. It engages in the research and development of novel new therapeutic agents designed to reduce oxidative stress and act as immuno-modulators and neuroprotectants. The company was founded by Thoma Kikis in 2010 and is headquartered in Doylestown, PA. | Health Technology |
Hempacco Co., Inc. |